Silicon Laboratories SLAB
- Market cap
- $7.4B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 8.6×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $855.9M
- +22% on a year ago
- Net margin
- −4.6%
- Free cash flow yield
- −0.1%
Silicon Laboratories trades at 8.6× sales. Its trailing earnings are negative, so it has no PE. Revenue was $855.9M over the last twelve months, up 22% on a year earlier with a −5% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $203.8M−25% | $86.8M−66% | $106.4M−57% | $145.4M−41% | $166.4M−18% | $166.2M+91% | $177.7M+67% | $192.8M+33% | $206M+24% | $208.2M+25% | $213.5M+20% | $228.2M+18% | |
| Cost of revenue | $84.7M−19% | $42.9M−57% | $51.3M−45% | $68.8M−32% | $76.1M−10% | $76M+77% | $79.9M+56% | $84.7M+23% | $87M+14% | $76.1M+0% | $86.5M+8% | $87.5M+3% |
| Gross profit | $119M−28% | $43.9M−72% | $55.1M−64% | $76.6M−47% | $90.3M−24% | $90.2M+105% | $97.8M+78% | $108.1M+41% | $119M+32% | $132.1M+46% | $127M+30% | $140.7M+30% |
| R&D | $79M−7% | $83.4M−4% | $80.7M−10% | $85.9M+0% | $83.2M+5% | $82.4M−1% | $88.2M+9% | $87.8M+2% | $87.7M+5% | $89.5M+9% | $88.6M+0% | $95M+8% |
| SG&A | $27.8M−45% | $33.6M−28% | $33.6M−25% | $38.7M−5% | $36.8M+33% | $36.4M+8% | $41.6M+24% | $43.2M+12% | $43.7M+19% | $45.8M+26% | $55.5M+33% | $56.3M+31% |
| $12.2M−60% | −$73.1M | −$59.1M | −$48M | −$29.7M | −$28.6M−61% | −$32.1M−46% | −$22.9M−52% | −$12.3M−59% | −$3.3M−89% | −$17.1M−47% | −$10.7M−53% | |
| Interest expense | $1.4M−11% | $943K−49% | $509K−69% | $263K−84% | $278K−80% | $260K−72% | $284K−44% | $251K−5% | $226K−19% | $214K−18% | $232K−18% | $251K+0% |
| Pre-tax income | $13.8M−59% | −$70.4M | −$56.9M | −$45.5M | −$26.5M | −$25.9M−63% | −$28.6M−50% | −$19.3M−58% | −$9.5M−64% | −$534K−98% | −$13.7M−52% | −$8.4M−56% |
| $3.4M−76% | −$15.5M | −$385K | $36.7M+197% | $2M−41% | −$2.1M−87% | $1.9M | $2.5M−93% | $414K−79% | $2.1M | $2.2M+16% | $2.2M−15% | |
| Net income | $10.3M−51% | −$69.8M | −$56.5M | −$82.2M | −$28.5M | −$23.8M−66% | −$30.5M−46% | −$21.8M−73% | −$9.9M−65% | −$2.7M−89% | −$15.9M−48% | −$10.6M−52% |
| $0.32−47% | −$2.19 | −$1.77 | −$2.56 | −$0.88 | −$0.73−67% | −$0.94−47% | −$0.67−74% | −$0.30−66% | −$0.08−89% | −$0.48−49% | −$0.32−52% | |
| 32.1M−8% | 31.8M−4% | 31.9M−6% | 32.1M−2% | 32.3M+1% | 32.4M+2% | 32.5M+2% | 32.7M+2% | 32.8M+2% | 32.9M+2% | 33M+2% | 33.2M+2% |
Net income: 55 periods, Q3 FY11 to Q1 FY25: not printed by the filing, worked out from its own lines.
EPS, diluted: 17 periods, Q4 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 12 periods, Q4 FY09 to Q4 FY22: share-days: the 12-month average less the 9-month, weighted by days. 5 periods, Q4 FY17 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Semiconductors nearest Silicon Laboratories' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| SLABSilicon Laboratories | $7.4B | n/m | 72.7× | 8.6× | +22% | −4.6% | |
| FORMFormfactor | $7.7B | 67.5× | 40.5× | 8.5× | +18% | 12.8% | |
| RMBSRambus | $9.3B | 39.3× | 45.4× | 12.3× | +17% | 31.7% | |
| CRUSCirrus Logic | $5.6B | 13.7× | 21.2× | 2.7× | +6% | 21.0% | |
| AMKRAmkor Technology | $9.8B | 17.6× | 14.5× | 1.3× | +18% | 7.4% | |
| NXTNextpower | $12B | 20.4× | 18.3× | 3.3× | +17% | 16.4% | |
| SMTCSemtech | $12.3B | 87.4× | 59.1× | 10.5× | +18% | 13.1% | |
| SWKSSkyworks Solutions | $12.6B | 43.2× | 19.8× | 3.1× | +0% | 7.2% | |
| ENPHEnphase Energy | $4.2B | 31.9× | 74.6× | 3.1× | −10% | 10.1% | |
| LSCCLattice Semiconductor | $13.7B | 370× | 86.4× | 21.0× | +33% | 5.6% | |
| KLICKulicke & Soffa Industries | $3.9B | 34.0× | 26.5× | 4.1× | +44% | 12.2% | |
| Peer median | $9.5B | 36.6× | 33.5× | 3.7× | +18% | 12.5% |
More on Silicon Laboratories
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Semiconductors
- Sector
- Technology
Valuation data, not investment advice. Prices as of .